183 related articles for article (PubMed ID: 1956058)
1. Do familial neural tube defects breed true?
Drainer E; May HM; Tolmie JL
J Med Genet; 1991 Sep; 28(9):605-8. PubMed ID: 1956058
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-1987.
Shaw GM; Jensvold NG; Wasserman CR; Lammer EJ
Teratology; 1994 Feb; 49(2):143-9. PubMed ID: 8016745
[TBL] [Abstract][Full Text] [Related]
3. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity.
Feuchtbaum LB; Currier RJ; Riggle S; Roberson M; Lorey FW; Cunningham GC
Genet Test; 1999; 3(3):265-72. PubMed ID: 10495925
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of neural tube defects.
Frey L; Hauser WA
Epilepsia; 2003; 44 Suppl 3():4-13. PubMed ID: 12790881
[TBL] [Abstract][Full Text] [Related]
5. [An estimate of recurrence risk for neural tube defects in China].
Wang Y; Wu Y; Zhou G; Xu C; Xiao K
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Jun; 27(2):196-8. PubMed ID: 9389042
[TBL] [Abstract][Full Text] [Related]
6. The changing incidence of neural tube defects in Scotland.
Davis CF; Young DG
J Pediatr Surg; 1991 May; 26(5):516-8. PubMed ID: 2061799
[TBL] [Abstract][Full Text] [Related]
7. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice.
Harris MJ; Juriloff DM
Teratology; 1999 Nov; 60(5):292-305. PubMed ID: 10525207
[TBL] [Abstract][Full Text] [Related]
8. A targeted sequencing panel identifies rare damaging variants in multiple genes in the cranial neural tube defect, anencephaly.
Ishida M; Cullup T; Boustred C; James C; Docker J; English C; ; Lench N; Copp AJ; Moore GE; Greene NDE; Stanier P
Clin Genet; 2018 Apr; 93(4):870-879. PubMed ID: 29205322
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence.
Dolk H; De Wals P; Gillerot Y; Lechat MF; Ayme S; Cornel M; Cuschieri A; Garne E; Goujard J; Laurence KM
Teratology; 1991 Nov; 44(5):547-59. PubMed ID: 1771596
[TBL] [Abstract][Full Text] [Related]
10. Studies in neural tube defects. I. Epidemiologic and etiologic aspects.
Myrianthopoulos NC; Melnick M
Am J Med Genet; 1987 Apr; 26(4):783-96. PubMed ID: 3296753
[TBL] [Abstract][Full Text] [Related]
11. A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China.
Li Z; Ren A; Zhang L; Guo Z; Li Z
Paediatr Perinat Epidemiol; 2006 Jan; 20(1):43-53. PubMed ID: 16420340
[TBL] [Abstract][Full Text] [Related]
12. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China.
Li Z; Ren A; Zhang L; Ye R; Li S; Zheng J; Hong S; Wang T; Li Z
Birth Defects Res A Clin Mol Teratol; 2006 Apr; 76(4):237-40. PubMed ID: 16575897
[TBL] [Abstract][Full Text] [Related]
13. Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study.
Canfield MA; Ramadhani TA; Shaw GM; Carmichael SL; Waller DK; Mosley BS; Royle MH; Olney RS;
Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):637-46. PubMed ID: 19334286
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic heterogeneity in neural tube defects: a clue to causal heterogeneity.
Martin RA; Fineman RM; Jorde LB
Am J Med Genet; 1983 Dec; 16(4):519-25. PubMed ID: 6362412
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation influences the distribution of neural tube defect subtypes: A registry-based study.
Bergman JE; Otten E; Verheij JB; de Walle HE
Reprod Toxicol; 2016 Jan; 59():96-100. PubMed ID: 26627544
[TBL] [Abstract][Full Text] [Related]
16. Weekly administration of folic acid and epidemiology of neural tube defects.
MartÃnez de Villarreal LE; Arredondo P; Hernández R; Villarreal JZ
Matern Child Health J; 2006 Sep; 10(5):397-401. PubMed ID: 16900407
[TBL] [Abstract][Full Text] [Related]
17. Glutamate carboxypeptidase II gene polymorphisms and neural tube defects in a high-risk Chinese population.
Xie H; Guo J; Wang J; Wang F; Zhao H; Liu C; Wang L; Lu X; Wu L; Bao Y; Zou J; Zhang T; Niu B
Metab Brain Dis; 2012 Mar; 27(1):59-65. PubMed ID: 22124883
[TBL] [Abstract][Full Text] [Related]
18. Clinical, genetic, and epidemiological factors in neural tube defects.
Hall JG; Friedman JM; Kenna BA; Popkin J; Jawanda M; Arnold W
Am J Hum Genet; 1988 Dec; 43(6):827-37. PubMed ID: 3195584
[TBL] [Abstract][Full Text] [Related]
19. A Shared Pathogenic Mechanism for Valproic Acid and
Takla TN; Luo J; Sudyk R; Huang J; Walker JC; Vora NL; Sexton JZ; Parent JM; Tidball AM
Cells; 2023 Jun; 12(13):. PubMed ID: 37443734
[TBL] [Abstract][Full Text] [Related]
20. Risks to sibs of probands with neural tube defects: data for clinic populations in British Columbia.
Keena B; Sadovnick AD; Baird PA; Hall JG
Am J Med Genet; 1986 Nov; 25(3):563-73. PubMed ID: 3538871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
